| 1 |
33084880 | Rationale and Design of the Genotype-Blinded Trial of Torasemide for the Treatment of Hypertension (BHF UMOD). | 2021 Feb 18 |
1 |
| 2 |
33788378 | The importance of sialic acid, pH and ion concentration on the interaction of uromodulin and complement factor H. | 2021 May |
1 |
| 3 |
34363725 | Associations of plasma uromodulin and genetic variants with blood pressure responses to dietary salt interventions. | 2021 Oct |
1 |
| 4 |
34869624 | Associations of Serum Uromodulin and Its Genetic Variants With Blood Pressure and Hypertension in Chinese Adults. | 2021 |
1 |
| 5 |
29361765 | Tamm-Horsfall Protein is a Potent Immunomodulatory Molecule and a Disease Biomarker in the Urinary System. | 2018 Jan 22 |
1 |
| 6 |
27898524 | Uromodulin in kidney health and disease. | 2017 Mar |
1 |
| 7 |
26683887 | Clinical, Genetic, and Urinary Factors Associated with Uromodulin Excretion. | 2016 Jan 7 |
2 |
| 8 |
22592667 | Common variants of the UMOD promoter associated with blood pressure in a community-based Chinese cohort. | 2012 Jul |
3 |
| 9 |
21082022 | Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. | 2010 Oct 28 |
1 |
| 10 |
15153749 | Urinary excretion rate of Tamm-Horsfall protein is related to salt intake in humans. | 2004 |
1 |